期刊文献+

糖尿病患者尿转化生长因子β1检测的临床意义 被引量:5

Clinical significance of Urinary transforming growth factor-β1 measurement in diabetics
下载PDF
导出
摘要 目的 探讨转化生长因子 β1(TGF β1)在糖尿病肾病早期诊断和判断病变严重程度中的临床价值。方法 采用酶联免疫吸附法 (ELISA)检测 70例 2型糖尿病患者和 2 0例正常人尿TGF β1。同时检测尿视黄醇结合蛋白、尿白蛋白、血糖、血肌酐等。结果 糖尿病患者尿TGF β1排泄较正常对照组增高 ,在正常蛋白尿时已经升高 ,并且随肾脏病情加重进一步增高 ;糖尿病组尿RBP排泄较正常对照组升高 ;尿TGF β1与视黄醇结合蛋白呈正相关。 结论 检测尿TGF β1对早期发现糖尿病肾病和监测其进展具有重要意义。 Objective To investigate the clinical value of transforming growth factor beta-1(TGF-β1) in diagnosis and severity assessment of diabetic nephropathy. Methods TGF-β1 was detected Using ELISA method in 70 patients with type 2 diabetes and 20 controls. Urinary retinal-binding protein(URBP) and urinary albumnin excretion rate(UAER) were also measured simultaneously. Results Urinary TGF-β1 levels significantly increased in diabetic patients even without obvious nephropathy compared with the controls(62.23±35.83) μg/mol vs (19.89±13.06) μg/mol,P<0.01) and furtherly increased as the nephropathy progressed. TGF-β1 was highly correlated with URBP which was significantly higher than in controls. Conclusion TGF-β1 might be an early marker for predicting diabetic nephropathy and assessing its severity.
出处 《安徽医科大学学报》 CAS 2003年第3期202-204,共3页 Acta Universitatis Medicinalis Anhui
基金 安徽省自然科学基金资助课题 (编号 :0 10 41181)
关键词 糖尿病 尿 转化生长因子Β1 检测 临床意义 诊断 糖尿病肾病 Diabetic nephropathies/urine tramsforming growth factor beta/urine retinol binding protein/ urine
  • 相关文献

参考文献12

  • 1叶山东,朱禧星.测定Ⅱ型糖尿病患者尿视黄醇结合蛋白的临床意义[J].中国糖尿病杂志,1997,5(2):93-95. 被引量:12
  • 2Sharma K, Ziyadeh FN. Hyperglycemia and diabetic. The case for transforming growth factor-beta as a key mediator. Diabetes, 1995;44(10) :1130-46.
  • 3Hoffman BB, Sharma K, Ziyadeh FN. Potential role of TGF-beta in diabetic nephropathy. Miner-Electrolyte-Metab. Kidney Int, 1998;24(2-3) :190-6.
  • 4Yamamoto T,Nohle NA,Cohen AH et al. Expression of transforming growth factor-b isoforms in human giomerular diseases.Kidney Int,1996;49(2) :461-9.
  • 5Wang SN, Lapage J, Hirschberg R et al. Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy. Kidney Int, 2000 ; 57(3) : 1002 - 14.
  • 6Wogensen L, Nielsen CB, Hjorth P et al. Under control of the Ren-1c promotor, locally produced transforming growth factorbetal induces a accumulation of glomerular extracellular matrix in transgenic mice. Diabetes, 1999 ; 48( 1 ) : 182 - 92.
  • 7Ellis D, Forrest KY, Erbey J et al. Urinary measurement of transforming growth factor-β1 and type iv collagen as new markers of renal injury: application in diabetic nephropathy Clinical Chemistry, 1998;44(5) :950-6.
  • 8Korpinen E, Teppo AM, Hukkanen Let al. Urinary transforming growth factor-beta1 and alphal-microglobulin in children and adolescents with type I diabetes. Diabetes-Care, 2000; 23(5):664-8.
  • 9Sharma K, Ziyadeh FN, Alzahabi B et al. Increased renal production of transforming growth factor-β1 in patirnts with type Ⅱ diabetes. Diabetes,1997;46(5) :854-9.
  • 10Sato H,Iwano M, Akai Y et al. Increased excretion of urinary transforming growth factor beta 1 in patients with diabetic nephropathy. Am J Nephro,1998;18(6) :490-4.

共引文献11

同被引文献39

  • 1何冰,韩萍,吕先科.2型糖尿病患者急性时相蛋白与糖尿病肾病的关系[J].中华内分泌代谢杂志,2003,19(4):260-262. 被引量:170
  • 2胡仲仪,邵世宏,邓跃毅.养阴固肾活血片对肾脏细胞外基质影响的实验研究[J].中国中西医结合肾病杂志,2000,1(3):144-145. 被引量:27
  • 3王瑞英,姚敏,王绵,苏胜偶.2型糖尿病模型大鼠肾小管上皮细胞中TGF-β1的表达及与肾功能的关系[J].中国老年学杂志,2005,25(5):549-551. 被引量:14
  • 4Ohga S, Shikata K, Yozai K, et aI. Thiazolidinedione ameliorates renaliniury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-kappaB activation. Am J Physiol Ren Physiol, 2007,292 : F1141-I1150.
  • 5Toblli JE, Ferrini MG, Cao G, et al. Antifibrotic effects of pioglitazone on the kidney in a rat model of type 2 diabetes melli- tus. Nephrol Dial Transplant, 2009,24 : 2384-2349.
  • 6Ko GJ, Kang YS, Han SY, et al. Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanismin type 2 diabetic rats. Nephrol Dial Transplant, 2008,23 : 2750-2760.
  • 7Wolf G. Cell cycle regulation in diabetic nephropathy. Kidney Int, 2000,58 :S59-S66.
  • 8Ziyadeh FN. Mediators of diabetic renal disease: the case for TGF-β as the major mediator. J Am Soc Nephrol, 2004,15:S55- S57.
  • 9Dessapt C, Baradez MO, Hayward A, et al. Mechanical forces and TGF{ beta} 1 reduce podocyte adhesion through { alpha} 3 {beta} 1 integrin downregulation. Nephrol Dial Transplant, 2009,24:2645-2655.
  • 10Guo B, Koya D, Isono M, et al. Peroxisome Proliferator-activated reeeptor-γ ligands inhibit TGF-β1-induced fibronectin ex- pression in glomerular mesangial cells. Diabetes, 2004, 53: 200-208.

引证文献5

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部